Exhibit 99.1 InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results — Miami, FL — March 18, 2026 – InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the fourth quarter and year ended December 31, 2025. Recent Business Highlights: "We continue to see robust early momentum in our U.S. business with CGuard Prime and growing demand internationally for ...